A phase II study of intensive chemotherapy with fludarabine, cytarabine, and mitoxantrone in P glycoprotein-negative high-risk myelodysplastic syndromes.
暂无分享,去创建一个
A. Stamatoullas | E. Wattel | P. Fenaux | E. Deconinck | N. Ifrah | F. Dreyfus | C. Fruchart | T. Prebet | S. Ducastelle | N. Gratecos | S. Debotton